TITLE

Developing international consensus on measures of improvement for patients with myositis

AUTHOR(S)
Lachenbruch, Peter A.; Miller, Frederick W.; Rider, Lisa G.
PUB. DATE
February 2007
SOURCE
Statistical Methods in Medical Research;Feb2007, Vol. 16 Issue 1, p51
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
We discuss methods of developing consensus in measuring improvement in myositis. We consider selecting candidate variables, reliability and validity, percentage improvement/worsening rules, rules based on CART and logistic regression. We discuss criteria for determining an acceptable rule that include both numerical measures and physician acceptance.
ACCESSION #
25219060

 

Related Articles

  • Prehospital transportation to therapeutic hypothermia centers and survival from out-of-hospital cardiac arrest. DeLia, Derek; Wang, Henry E.; Kutzin, Jared; Merlin, Mark; Nova, Jose; Lloyd, Kristen; Cantor, Joel C. // BMC Health Services Research;12/2/2015, Vol. 15, p1 

    Background: Clinical trials supporting the use of therapeutic hypothermia (TH) in the treatment of out-of-hospital cardiac arrest (OHCA) are based on small patient samples and do not reflect the wide variation in patient selection, cooling methods, and other elements of post-arrest...

  • Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Sydes, Matthew R; Altman, Douglas G; Babiker, Abdel B; Parmar, Mahesh K B; Spiegelhalter, David J // Clinical Trials;2004, Vol. 1 Issue 1, p48 

    Background We describe a review of published main reports of randomized controlled trials (RCTs), in order to measure the frequency of reported use of data monitoring committees (DMCs) and factors associated with reported DMC use. Methods Twenty-four higher impact general and specialist medical...

  • Perspectives of staff nurses of the reasons for and the nature of patient-initiated call lights: an exploratory survey study in four USA hospitals. Huey-Ming Tzeng // BMC Health Services Research;2010, Vol. 10, p52 

    Background: Little research has been done on patient call light use and staff response time, which were found to be associated with inpatient falls and satisfaction. Nurses' perspectives may moderate or mediate the aforementioned relationships. This exploratory study intended to understand...

  • TO PREDICT DISEASE OUTCOME: CLINICAL RISK FACTORS PLUS GENETIC-STAGING FOR CANCER. Shu-Kay Ng // Pakistan Journal of Statistics;2010, Vol. 26 Issue 1, p171 

    Studies on genetic profiling demonstrate its potential utility for classifying tumours, leading to a .genetic-staging. system for predicting disease outcomes. A precise prediction of individual disease outcome is important to identify patients who have a high risk of disease recurrence, and to...

  • Switching HMO Providers. Foo Nin Ho; O'Donnell, Kathleen A.; Yi-Ju Chen // Marketing Health Services;Spring98, Vol. 18 Issue 1, p23 

    The article presents the results of statistical research into the determinants for health maintenance organization (HMO) switching behavior in consumers. The distinctions between the causes of initial selection and those for continuing enrollment or subsequent changes in service providers are...

  • Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study. Sugano, Naoki; Maruyama, Yukio; Kidoguchi, Satoshi; Ohno, Iwao; Wada, Atsushi; Shigematsu, Takashi; Masakane, Ikuto; Yokoo, Takashi // PLoS ONE;6/6/2019, Vol. 14 Issue 6, p1 

    Whether higher serum uric acid (UA) values comprise a risk factor for death and whether treatment for high UA is effective in patients undergoing hemodialysis (HD) are essentially unknown. To determine associations between UA and all-cause or cardiovascular (CV) mortality, interactions between...

  • Cancer patients’ acceptability of incorporating an epidemiology questionnaire within a clinical trial. Cuffe, Sinead; Hon, Henrique; Tobros, Kimberly; Espin-Garcia, Osvaldo; Brhane, Yonathan; Harland, Luke; Fadhel, Ehab; Eng, Lawson; LaDelfa, Anthony; Waldron, John; Siu, Lillian L; Chen, Bingshu E; Xu, Wei; Simmons, Christine; Kassam, Zahra; Montenegro, Alexander; Parulekar, Wendy R; Liu, Geoffrey // Clinical Trials;Jun2015, Vol. 12 Issue 3, p237 

    No abstract available.

  • Randomized clinical trials to identify optimal antibiotic treatment duration. Horsburgh, C. Robert; Shea, Kimberly M.; Phillips, Patrick; LaValley, Michael // Trials;2013, Vol. 14 Issue 1, Special section p1 

    Background: Antibiotic resistance is a major barrier to the continued success of antibiotic treatment. Such resistance is often generated by overly long durations of antibiotic treatment. A barrier to identifying the shortest effective treatment duration is the cost of the sequence of clinical...

  • Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies. Healy, Brian; Chitnis, Tanuja; Engler, David // Journal of Neurology;Oct2011, Vol. 258 Issue 10, p1812 

    In patients with multiple sclerosis, investigation of a treatment effect on disease progression in clinical trials and observational studies often uses sustained progression on the expanded disability status scale (EDSS) as an outcome. It is not clear whether this outcome is the most powerful to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics